Cargando…
Melanoma Cells Present a MAGE-3 Epitope to CD4(+) Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
In this study we used TEPITOPE, a new epitope prediction software, to identify sequence segments on the MAGE-3 protein with promiscuous binding to histocompatibility leukocyte antigen (HLA)-DR molecules. Synthetic peptides corresponding to the identified sequences were synthesized and used to propag...
Autores principales: | Manici, Simona, Sturniolo, Tiziana, Imro, Maria Adele, Hammer, Juergen, Sinigaglia, Francesco, Noppen, Christoph, Spagnoli, Giulio, Mazzi, Benedetta, Bellone, Matteo, Dellabona, Paolo, Protti, Maria Pia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192952/ https://www.ncbi.nlm.nih.gov/pubmed/10049951 |
Ejemplares similares
-
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
por: Jäger, Elke, et al.
Publicado: (1998) -
The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity
por: Rajagopalan, Sumati, et al.
Publicado: (1997) -
Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis
por: Borrego, Francisco, et al.
Publicado: (1998) -
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells
por: Moniruzzaman, Md, et al.
Publicado: (2023) -
MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)